(PLCE) Children’s Place - Overview
Stock: Apparel, Accessories, Footwear
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 118% |
| Relative Tail Risk | -26.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -80.84 |
| Character TTM | |
|---|---|
| Beta | 1.756 |
| Beta Downside | 1.881 |
| Drawdowns 3y | |
|---|---|
| Max DD | 92.05% |
| CAGR/Max DD | -0.60 |
Description: PLCE Children’s Place January 19, 2026
The Children’s Place, Inc. (NASDAQ: PLCE) runs an omni-channel specialty retailer focused on children’s apparel, accessories and footwear across North America, operating under the brands The Children’s Place, Gymboree, Sugar & Jade and PJ Place. Its business is split into two reporting segments – The Children’s Place U.S. and The Children’s Place International – and it reaches customers via brick-and-mortar stores, its own e-commerce sites (e.g., childrensplace.com, gymboree.com), wholesale partners and international franchisees.
In FY 2023 the company generated roughly $2.2 billion in revenue, with e-commerce sales growing about 15 % year-over-year and now representing close to 30 % of total sales. Same-store sales in the U.S. segment were flat to slightly negative, reflecting broader consumer-discretionary softness, while the International segment contributed a modest 5 % of total revenue but showed higher growth rates due to expanding franchise operations.
Key drivers for The Children’s Place include U.S. household spending on children’s apparel (a sector that historically moves with disposable income and demographic trends), inflation-driven price sensitivity, and the seasonal back-to-school calendar that can boost quarterly sales. Supply-chain resilience and inventory turnover remain critical, as the company relies on contracted manufacturers to keep margins stable in a competitive retail environment.
For a deeper quantitative breakdown, see the ValueRay analysis of PLCE.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -51.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 19.00 > 1.0 |
| NWC/Revenue: -3.30% < 20% (prev -3.23%; Δ -0.07% < -1%) |
| CFO/TA 0.07 > 3% & CFO 54.1m > Net Income -51.7m |
| Net Debt (570.4m) to EBITDA (22.8m): 24.97 < 3 |
| Current Ratio: 0.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.2m) vs 12m ago 73.20% < -2% |
| Gross Margin: 28.61% > 18% (prev 0.29%; Δ 2833 % > 0.5%) |
| Asset Turnover: 156.0% > 50% (prev 161.2%; Δ -5.18% > 0%) |
| Interest Coverage Ratio: -0.28 > 6 (EBITDA TTM 22.8m / Interest Expense TTM 33.5m) |
Altman Z'' -1.80
| A: -0.06 (Total Current Assets 490.2m - Total Current Liabilities 532.7m) / Total Assets 762.5m |
| B: -0.31 (Retained Earnings -236.4m / Total Assets 762.5m) |
| C: -0.01 (EBIT TTM -9.50m / Avg Total Assets 825.7m) |
| D: -0.33 (Book Value of Equity -251.2m / Total Liabilities 771.1m) |
| Altman-Z'' Score: -1.80 = D |
Beneish M -3.07
| DSRI: 1.12 (Receivables 62.5m/62.2m, Revenue 1.29b/1.43b) |
| GMI: 1.00 (GM 28.61% / 28.71%) |
| AQI: 1.11 (AQ_t 0.03 / AQ_t-1 0.02) |
| SGI: 0.90 (Revenue 1.29b / 1.43b) |
| TATA: -0.14 (NI -51.7m - CFO 54.1m) / TA 762.5m) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of PLCE shares?
Over the past week, the price has changed by -2.86%, over one month by -4.24%, over three months by -40.41% and over the past year by -55.52%.
Is PLCE a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PLCE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.5 | 10.6% |
| Analysts Target Price | 4.5 | 10.6% |
| ValueRay Target Price | 2.2 | -45.7% |
PLCE Fundamental Data Overview February 03, 2026
P/S = 0.0694
P/B = 2.4285
P/EG = 1.79
Revenue TTM = 1.29b USD
EBIT TTM = -9.50m USD
EBITDA TTM = 22.8m USD
Long Term Debt = 107.4m USD (from longTermDebt, last quarter)
Short Term Debt = 353.5m USD (from shortTermDebt, last quarter)
Debt = 577.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 570.4m USD (from netDebt column, last quarter)
Enterprise Value = 659.8m USD (89.3m + Debt 577.7m - CCE 7.25m)
Interest Coverage Ratio = -0.28 (Ebit TTM -9.50m / Interest Expense TTM 33.5m)
EV/FCF = 16.61x (Enterprise Value 659.8m / FCF TTM 39.7m)
FCF Yield = 6.02% (FCF TTM 39.7m / Enterprise Value 659.8m)
FCF Margin = 3.08% (FCF TTM 39.7m / Revenue TTM 1.29b)
Net Margin = -4.01% (Net Income TTM -51.7m / Revenue TTM 1.29b)
Gross Margin = 28.61% ((Revenue TTM 1.29b - Cost of Revenue TTM 919.6m) / Revenue TTM)
Gross Margin QoQ = 30.92% (prev 31.44%)
Tobins Q-Ratio = 0.87 (Enterprise Value 659.8m / Total Assets 762.5m)
Interest Expense / Debt = 1.41% (Interest Expense 8.13m / Debt 577.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -7.50m (EBIT -9.50m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.92 (Total Current Assets 490.2m / Total Current Liabilities 532.7m)
Debt / Equity = -67.09 (negative equity) (Debt 577.7m / totalStockholderEquity, last quarter -8.61m)
Debt / EBITDA = 24.97 (Net Debt 570.4m / EBITDA 22.8m)
Debt / FCF = 14.36 (Net Debt 570.4m / FCF TTM 39.7m)
Total Stockholder Equity = -17.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.26% (Net Income -51.7m / Total Assets 762.5m)
RoE = 289.3% (negative equity) (Net Income TTM -51.7m / Total Stockholder Equity -17.9m)
RoCE = -10.61% (EBIT -9.50m / Capital Employed (Equity -17.9m + L.T.Debt 107.4m))
RoIC = -1.98% (negative operating profit) (NOPAT -7.50m / Invested Capital 378.0m)
WACC = 2.62% (E(89.3m)/V(667.0m) * Re(12.39%) + D(577.7m)/V(667.0m) * Rd(1.41%) * (1-Tc(0.21)))
Discount Rate = 12.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 32.55%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈39.7m ; Y1≈26.1m ; Y5≈11.9m
Fair Price DCF = N/A (negative equity: EV 379.2m - Net Debt 570.4m = -191.3m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -2.55 | EPS CAGR: -3.41% | SUE: -0.02 | # QB: 0
Revenue Correlation: -54.51 | Revenue CAGR: -10.18% | SUE: -1.35 | # QB: 0
EPS next Quarter (2026-04-30): EPS=-1.13 | Chg30d=-0.019 | Revisions Net=-1 | Analysts=1
EPS next Year (2027-01-31): EPS=-0.95 | Chg30d=-1.508 | Revisions Net=-1 | Growth EPS=+64.7% | Growth Revenue=+1.3%